A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly's Q1
29/4 08:25
Eli Lilly stock (NYSE: LLY) will report its Q1 results on Tuesday, April 30. The pharmaceutical giant is expected to garner $8.9 billion in sales and $2.46 in adjusted earnings per share, per the consensus estimates. All eyes will be on Eli Lilly’s diabetes drug – Mou...